ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 40 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $235,000 | +164.0% | 668,600 | +64.0% | 0.03% | +200.0% |
| Q4 2019 | $89,000 | +270.8% | 407,794 | +295.0% | 0.01% | +350.0% |
| Q3 2019 | $24,000 | +33.3% | 103,245 | +43.0% | 0.00% | +100.0% |
| Q2 2019 | $18,000 | -57.1% | 72,199 | -17.0% | 0.00% | -50.0% |
| Q1 2019 | $42,000 | +27.3% | 87,012 | +3.4% | 0.00% | 0.0% |
| Q4 2018 | $33,000 | -77.4% | 84,128 | -57.0% | 0.00% | -77.8% |
| Q3 2018 | $146,000 | +135.5% | 195,623 | +103.1% | 0.01% | +200.0% |
| Q2 2018 | $62,000 | +933.3% | 96,305 | +526.9% | 0.00% | – |
| Q1 2018 | $6,000 | -90.8% | 15,363 | -84.3% | 0.00% | -100.0% |
| Q4 2017 | $65,000 | +170.8% | 97,849 | +134.2% | 0.00% | +200.0% |
| Q3 2017 | $24,000 | – | 41,774 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,590,267 | $915,000 | 0.48% |
| ARMISTICE CAPITAL, LLC | 4,382,000 | $2,520,000 | 0.30% |
| DAFNA Capital Management LLC | 333,000 | $192,000 | 0.12% |
| SABBY MANAGEMENT, LLC | 2,434,103 | $1,400,000 | 0.09% |
| Anson Funds Management LP | 1,024,592 | $589,000 | 0.09% |
| Hartford Financial Management Inc. | 18,000 | $10,000 | 0.01% |
| Summit X, LLC | 11,000 | $7,000 | 0.01% |
| SNS Financial Group, LLC | 18,000 | $10,000 | 0.00% |
| DOWLING & YAHNKE LLC | 22,870 | $13,000 | 0.00% |
| A.R.T. Advisors, LLC | 30,005 | $17,000 | 0.00% |